Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer

Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer

(2012) Ryaz Chagpar et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias

(2012) Hae Sun Suh et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Increased Screening Colonoscopy Rates and Reduced Racial Disparities in the New York Citywide Campaign: An Urban Model

(2011) Catherine A Richards et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Survival disparities by Medicaid status

(2011) Siran M. Koroukian et al.   CANCER

Racial and ethnic differences in lymph node examination after colon cancer resection do not completely explain disparities in mortality

(2011) Kim F. Rhoads et al.   CANCER

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

(2011) Greg Yothers et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features

(2011) Erin S. O'Connor et al.   JOURNAL OF CLINICAL ONCOLOGY

Racial Disparities in Stage-Specific Colorectal Cancer Mortality Rates From 1985 to 2008

(2011) Anthony S. Robbins et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Survival Results of Surgery Alone Versus Surgery Plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer: Pooled Analysis of NSABP C-01 Through C-05. A Baseline from Which to Compare Modern Adjuvant Trials

(2010) Neal W. Wilkinson et al.   ANNALS OF SURGICAL ONCOLOGY

Race and Colorectal Cancer Disparities: Health-Care Utilization vs Different Cancer Susceptibilities

(2010) A. O. Laiyemo et al.   JNCI-Journal of the National Cancer Institute

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

(2009) M. Ychou et al.   ANNALS OF ONCOLOGY

The National Cancer Data Base: Past, Present, and Future

(2009) David P. Winchester et al.   ANNALS OF SURGICAL ONCOLOGY

A black-white comparison of the quality of stage-specific colon cancer treatment

(2009) Jamillah Berry et al.   CANCER

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

(2009) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Insurance Status, Comorbidity Level, and Survival Among Colorectal Cancer Patients Age 18 to 64 Years in the National Cancer Data Base From 2003 to 2005

(2009) Anthony S. Robbins et al.   JOURNAL OF CLINICAL ONCOLOGY

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

(2009) Daniel Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

(2008) Karl Y. Bilimoria et al.   ANNALS OF SURGICAL ONCOLOGY

Rates and predictors of chemotherapy use for stage III colon cancer

(2008) David A. Etzioni et al.   CANCER